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A B S T R A C T
Glaucoma is a common cause of visual impairment and blindness, characterized by retinal ganglion cell (RGC)
death. The mechanisms that trigger the development of glaucoma remain unknown and have gained signiﬁcant
relevance in the study of this neurodegenerative disease. P2X7 purinergic receptors (P2X7R) could be involved
in the regulation of the synaptic transmission and neuronal death in the retina through diﬀerent pathways. The
aim of this study was to characterize the molecular signals underlying glaucomatous retinal injury.
The time-course of functional, morphological, and molecular changes in the glaucomatous retina of the DBA/
2J mice were investigated. The expression and localization of P2X7R was analysed in relation with retinal
markers. Caspase-3, JNK, and p38 were evaluated in control and glaucomatous mice by immunohistochemical
and western-blot analysis. Furthermore, electroretinogram recordings (ERG) were performed to assess inner
retina dysfunction.
Glaucomatous mice exhibited changes in P2X7R expression as long as the pathology progressed. There was
P2X7R overexpression in RGCs, the primary injured neurons, which correlated with the loss of function through
ERG measurements. All analyzed MAPK and caspase-3 proteins were upregulated in the DBA/2J retinas sug-
gesting a pro-apoptotic cell death.
The increase in P2X7Rs presence may contribute, together with other factors, to the changes in retinal
functionality and the concomitant death of RGCs. These ﬁndings provide evidence of possible intracellular
pathways responsible for apoptosis regulation during glaucomatous degeneration.
1. Introduction
Glaucoma is a neurodegenerative disease characterized by optic
nerve degeneration and retinal ganglion cell (RGC) death (Quigley and
Broman, 2006; Schlamp et al., 2006; Howell et al., 2007). It is often
correlated with an elevated intraocular pressure (IOP) (Schuettauf
et al., 2004; Salinas-Navarro et al., 2009; Cuenca et al., 2010; Salinas-
Navarro et al., 2010). RGC injury during glaucomatous optic neuro-
pathy development is one of the main reasons that lead to blindness,
this being originated by the contribution of several factors. In this sense,
glutamate-induced excitotoxicity (Casson, 2006), hypoxic insult, neu-
rotrophic deprivation (Johnson et al., 2009) and oxidative stress (Tezel,
2006; McElnea et al., 2011; Goyal et al., 2014) play additional roles in
the pathogenesis of glaucoma. These insults have pointed to cell death
by apoptotic processes (Jakobs et al., 2005; Zhou et al., 2005). Pro-
gramed cell death can contribute to RGC loss in diﬀerent models of
glaucoma (Sawada and Neufeld, 1999; Ko et al., 2000; Tatton et al.,
2001; Zhang et al., 2005) and optic nerve transection (Agudo et al.,
2008, 2009; Levkovitch-Verbin et al., 2013; Levkovitch-Verbin, 2015;
Sanchez-Migallon et al., 2016, 2018). Markers of apoptosis have also
been observed in the human glaucomatous retina (Kerrigan et al., 1997;
Okisaka et al., 1997).
There is compelling evidence that purinergic receptors have an
important role in ocular structures. The P2X7 receptor (P2X7R) is a
ligand–gated ion channel that belongs to P2X purinergic receptors fa-
mily. The P2X7 is activated by low concentrations of extracellular ATP
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(Surprenant et al., 1996). Its prolonged activation elicits the opening of
a transmembrane pore, permeable to large molecular weight molecules
which ﬁnally leads to cellular death (Di Virgilio et al., 1998). The
P2X7R has been detected in neurons (Wheeler-Schilling et al., 2001;
Ishii et al., 2003; Puthussery and Fletcher, 2004; Puthussery et al.,
2006; Vessey and Fletcher, 2012), microglial cells (Franke et al., 2005;
Vessey and Fletcher, 2012), and astrocytes (Vessey and Fletcher, 2012)
from rodent and primate retina.
The P2X7R is expressed in diﬀerent layers in the retina and has been
implicated in neurodegenerative diseases including neuroimmune and
neuroinﬂammatory reactions (Skaper et al., 2010; Weisman et al.,
2012; Catanzaro et al., 2014). Electrophysiological, pharmacological
and immunological studies evidence the presence and the role of P2X7
in neuronal functions and injury. Several studies have demonstrated the
involvement of P2X7R in retinal impairment. Increased levels of ATP
and P2X7R activation were observed in hypertensive models of glau-
comatous damage in in vitro (Resta et al., 2005; Reigada et al., 2008; Hu
et al., 2010; Xia et al., 2012) and in vivo models (Zhang et al., 2007; Li
et al., 2011; Niyadurupola et al., 2013; Sugiyama et al., 2013). Fur-
thermore, P2X7R activation may also be associated with hypoxia-in-
duced death of retinal neurons (Sugiyama et al., 2010) and retinitis
pigmentosa model (Franke et al., 2005).
Stimulation of P2X7R is involved in the modulation of neuronal
retinal neurotransmission (Puthussery et al., 2006) and neuronal death
(Franke et al., 2005) in murine models and in primary retinal cultures
(Resta et al., 2005; Reigada et al., 2008; Hu et al., 2010; Sugiyama
et al., 2010). Furthermore, this stimulation increases protein tyrosine
phosphorylation (Adinolﬁ et al., 2003; Aga et al., 2004) leading to
MAPK pathway activation, proteins which have a determinant role in
the commitments of the cells to apoptosis (Panenka et al., 2001; Wang
et al., 2003; Kong et al., 2005). Due to these ﬁndings, recent studies
suggest a protective role of the P2X7R antagonists (Di Virgilio et al.,
2001; Franke et al., 2004; Jun et al., 2007; Diaz-Hernandez et al.,
2009).
An interesting model of glaucoma where the retinal changes and the
participation of P2X7 receptors can be studied is the DBA/2J mouse.
This is a well-established model for secondary angle-closure glaucoma
(Jakobs et al., 2005; Anderson et al., 2006), caused by mutations in the
Gpnmb and Tyrp genes (John et al., 1998; Anderson et al., 2002; Libby
et al., 2005; Anderson et al., 2006; Howell et al., 2007). DBA/2J pre-
sents a gradual increase in IOP, which is maximal between the 9th and
12th month of age (Anderson et al., 2002). This rise in the IOP is mainly
due to the iris pigment dispersion in the eye anterior chamber produced
by iris atrophy (Anderson et al., 2002). The rise in IOP might be the key
factor that produces retinal cell damage in this animal model (Inman
et al., 2006). Interestingly, retinal cell death will concomitantly pro-
duce a visual dysfunction that can be recorded by electroretinography
(Alarcon-Martinez et al., 2009; Salinas-Navarro et al., 2009; Cuenca
et al., 2010; Montalban-Soler et al., 2012; Perez de Lara et al., 2014;
Smith et al., 2014).
In this sense, the present study focused on the characterization of a
murine spontaneous model of glaucoma, the DBA/2J, and the possible
role of activated/up-regulated P2X7R by ATP in RGC death during the
development of the pathology. To understand the RGC death me-
chanism we investigated whether the activated apoptotic cascades in
RGC death were associated with alterations in the activation of mi-
togen-activated protein kinases (MAPK) signaling pathways.
2. Materials and methods
2.1. Animal handling
The experiments were performed on female DBA/2J (n=26) and
C57BL/6J (n=26) mice obtained from the European distributor of the
Jackson Laboratories (Charles Rivers Laboratories). All animal main-
tenance and experimental procedures followed in compliance with
institutional, Spanish and European guidelines of animal care in the
laboratory and animal research (Guide for the Care and Use of
Laboratory Animals) and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. All animal studies were performed
with authorization of the institutional Animal Care and Use Committee
from the Complutense University of Madrid (Spain). Four mice were
housed per cage in temperature and light-controlled rooms maintained
on a 12 h light/dark cycle, and all animals had access to food and water
ad libitum. DBA/2J and C57BL/6J mice were studied at 3 and 15
months. C57BL/6J mice were used as control.
For ERG measurements, mice were weighted and anesthetized with
an intraperitoneal (i.p.) injection of a mixture of ketamine (95mg/kg,
Imalgene 1000®, Merial Laboratorios, S.A., Barcelona, Spain) and xy-
lazine (5mg/kg, Rompun®, Bayer, S.A, Barcelona, Spain). While re-
covering from anesthesia, mice were placed in their cages, and an
ocular ointment containing neomycin and prednisone (Oftalmolosa
Cusí Prednisona-Neomicina®; Alcon S.A., Barcelona, Spain) was applied
on the cornea to prevent corneal desiccation. Animals were euthanized
with an i.p. injection of an overdose of 20% sodium pentobarbital
(Dolethal®;Vetoquinol Especialidades Veterinarias, S.A., Alcobendas,
Madrid, Spain).
The DBA/2J mice were genotyped by PCR on the tail DNA
(Mangiarini et al., 1996) to assure the presence the mutations in Tyrp1
and Gpnmb genes (data not shown) (Perez de Lara et al., 2014).
2.2. Electroretinogram recordings
The mice (n= 12 mice for each group) were adapted to darkness
overnight before electroretinogram recordings (ERG), and all manip-
ulation procedures were performed under dim red light (λ>600 nm).
Anaesthesia was induced by i.p. injection of a mixture of ketamine and
xylazine in saline (see above) and kept on a heating pad to maintain
normal body temperature at 37 °C. Pupil mydriasis was induced by
applying a topical drop of 1% tropicamide (Colircusí Tropicamida 1%®;
Alcon-Cusí, S.A., El Masnou, Barcelona, Spain) in the right eye of the
experimental animal before placing the corneal electrode. The re-
cording system comprised Burian-Allen lens electrodes (Hansen Labs,
Coralville, Iowa, USA) positioned on the cornea. The corneal surface
had been previously protected with a drop of methylcellulose (Methocel
2%®; Novartis Laboratories CIBA Vision, Annonay, France) to maximize
conductivity. The reference electrode was placed in the mouth, and the
ground electrode was inserted subcutaneously at the base of the tail.
After positioning the electrodes, the mice resting on the warming pad
were placed in a Ganzfeld stimulator. Flash-induced ERG stimulation
was provided by a Ganzfeld dome light source, which ensured a uni-
form illumination of the retina and provided a wide range of light in-
tensities. Electrical signals generated in the retina were ampliﬁed
(x1000) and band ﬁltered between 0.3 and 1000 Hz, using an ampliﬁer
(CP511 AC ampliﬁer; Grass Instruments, Quincy, MA). Electrical signals
were digitized at 20 kHz, using a data acquisition board (PowerLab; AD
Instruments, Chalgrove, UK) and displayed on a PC computer monitor.
Light stimuli were calibrated periodically with a photometer (Mavo
Monitor USB, Gossen, Nürenberg, Germany). The scotopic responses
elicited by stimulation of the retina with light intensities increasing
from 10−5 to 10−2 cd·s·m−2 were recorded in the right eye to de-
termine the Scotopic Threshold Response (STR). A series of ERG re-
sponses were averaged (≈20 ERGs for each trace) for each light in-
tensity, after adjusting the time interval between ﬂashes to ensure
complete recovery of the response (10 s for the dimmest stimulus in-
tensities and 30 s for the strongest stimuli). Standard ERG waves were
analyzed according to the method recommended by the International
Society for Clinical Electrophysiology of Vision (ISCEV).
2.2.1. Analysis and statistics
For the statistical analysis, the positive scotopic threshold response
(pSTR) was measured from the baseline to the peak of the positive
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deﬂection (110–120ms after the ﬂash onset), whereas the negative
scotopic threshold response (nSTR) was measured from the baseline to
the peak of the negative deﬂection after the pSTR (approximately
220ms from the ﬂash onset). The C57BL/6J and DBA/2J recordings
were compared at diﬀerent ages for each light stimulus using GraphPad
InStat® 3 for Windows® (GraphPad Software, San Diego California
USA,). Descriptive statistics were calculated and the normality of the
distribution of the data was examined. The Student’s t-test was applied
to compare the averaged diﬀerences (mean ± SEM) of ERG responses
of the right eyes at -3.69 log cd·s·m−2 in both groups at diﬀerent ages.
Values were considered statistically signiﬁcant when p < 0.05 for all
tests.
2.3. Morphological study
A subpopulation of the animals used to study the ERG changes re-
lated with the age were used in the immunohistochemical study.
C57BL/6J and DBA/2J mice at 3 and 15 months (n=12 mice for each
group) were deeply anesthetized, the orientation of the eyes was pre-
served by a suture stitch placed on the superior pole, and were perfused
transcardially with 0.1M phosphate buﬀer saline (PBS; pH 7.2–7.4)
followed by a ﬁxative solution of 4% paraformaldehyde in 0.1 M
phosphate buﬀer (PB; pH 7.2–7.4) at 4 °C. The eyes were enucleated
and immersed in the same ﬁxative solution for 1 h at 4 °C. The anterior
segment and the lens were removed and the eyecups were post-ﬁxed for
30min. at 4 °C and rinsed in PBS.
For retinal whole-mount studies both retinas were dissected out and
prepared as ﬂatten whole-mount by making four radial cuts in each
retinal pole (the deepest in the superior pole) as previously described
(Lindqvist et al., 2004; Salinas-Navarro et al., 2009; Galindo-Romero
et al., 2011; Perez de Lara et al., 2014; Valiente-Soriano et al., 2015).
To identify the expression of P2X7 and NF in the retina at the time
of animal sacriﬁce a simultaneous double immunostaining was per-
formed using a rabbit polyclonal anti-P2X7 receptor (Alomone Labs)
and a mouse monoclonal anti-pNFH (Serotec) at the working dilution
indicated in Table 1. Retinas were pre-incubated in a blocking solution
of 2% Triton X-100 in PBS containing 2% normal serum from the
species that the secondary antibodies were raised in (goat and donkey,
see Table 1), for 1 h at RT. Incubation with both primary antibodies was
carried out in blocking solution overnight at 4 °C. After gentle rinse
with 0.1% Triton X-100 in PBS, retinas were incubated with a mix of
both secondary antibodies diluted 1:500 in blocking solution for 1 h at
RT. After rinsing with 0.1% Triton X-100 in PBS, retinas were ﬂat
mounted on slides with the vitreal side up and covered with antifading
mounting media containing 50% glycerol and 0.04% p-phenylenedia-
mine in 0.1 M sodium carbonate buﬀer (pH 9.0).
Retinas were examined and photographed under a ﬂuorescence
microscope (Axioscop 2 Plus; Zeiss Mikroskopie, Jena, Germany)
equipped with a ﬂuorescein (BP 450/490, LP 515-565) and a rhoda-
mine (BP 546/12, LP590) ﬁlter to observe the secondary Alexa Fluor®-
488 or -568 conjugated antibodies (donkey anti rabbit and goat anti
mouse, respectively). The microscope was also equipped with a digital
high-resolution camera (ProgRes™ C10plus; Jenoptik, Jena, Germany)
and a computer-driven motorized stage (ProScan™ H128 Series; Prior
Scientiﬁc Instruments, Cambridge, UK) connected to image analysis
software (Image-Pro Plus 5.1 for Windows (IPP); Media Cybernetics,
Silver Spring, MD, USA) through a microscope controller module
(Scope-Pro 5.0 for Windows; Media Cybernetics, Silver Spring, MD,
USA). Retinal whole-mount reconstructions were carried out following
previously described procedures (Vidal-Sanz et al., 2015, 2017). For
retinal cross section studies, after rinsing in PBS the eyecups were im-
mersed in graded sucrose in PBS (11% and 33%) for cryoprotection at
4 °C. Eyecups were oriented to get vertical sections by embedding in
tissue freezing medium (Tissue-Tek© OCT™ Compound; Sakura® Finitek
Europe, B.V. Alphen van den Rijn, The Netherlands), frozen in 2-me-
thylbutane (Sigma-Aldrich Quimica SL, Madrid, Spain) cooled with li-
quid nitrogen and 10 μm frozen sections were obtained on a cryostat
(Microm, Walldorf, Germany). Sections were collected on poly-L-lysine
coated slides and stored at −20 °C until use.
For single or double immunoﬂuorescence studies, slices were
thawed and permeabilized with 0.25% Triton X-100 in PBS for 30min,
followed by pre-incubation with the blocking solution, containing 10%
normal donkey serum (NDS; Jackson ImmunoResearch, West Grove,
PA, USA), 10% normal goat serum (NGS; Jackson ImmunoResearch),
and 0.1% Triton X-100 in PBS for 1 h at room temperature. The slices
were incubated with the primary antibodies (see Table 1) diluted in
PBS-0.1% Tx-100 and 1% normal donkey or goat serum (depending on
the species of the secondary antibody) overnight at 4 °C. All primary
antibodies utilized in this study have been used previously in the rodent
retina (Pannicke et al., 2000; Munemasa et al., 2005; Barhoum et al.,
2008; Nadal-Nicolas et al., 2009; Parrilla-Reverter et al., 2009;
Donovan et al., 2011; Diaz-Hernandez et al., 2012). Finally, sections
were washed in PBS-0.1% Tx-100 and incubated with respective sec-
ondary antibodies diluted in PBS-0.1% Tx-100, for 1 h, in darkness at
RT. Secondary antibodies used were Cy3-conjugated donkey anti-rabbit
IgG(H+ L) (1:200) or FITC-conjugated donkey anti-rabbit IgG(H+L)
(1:200) and FITC-conjugated donkey anti-mouse IgG (H+L) (Jackson
ImmunoResearch). Subsequently, sections were rinsed in PBS and
mounted in antifade mounting medium (Vectashield®; Vector Labora-
tories, Burlingame, CA, USA).
Sections were examined and photographed under a confocal mi-
croscope (Zeiss LSM 5 Zeiss Mikroskopie, Jena, Germany) equipped
with an argon laser (458/488/514 nm) and a helium-neon laser
(543 nm). The microscope was also equipped with a digital high-re-
solution camera (ProgRes™ C10plus; Jenoptik, Jena, Germany) and a
computer-driven motorized stage (ProScan™ H128 Series; Prior
Scientiﬁc Instruments, Cambridge, UK) connected to image analysis
software. Images were collected with a resolution of 512×512 pixels
(250 x 250 μm) and projections of four frames using the single or the
multi-track scanning module. Images acquired were processed using
Adobe Photoshop 8.0 software (Adobe Systems, Inc., San Jose, CA,
USA).
Table 1
Primary antibodies.
Molecular marker Antibody IH dilution WB dilution Source
P2X7 receptor Rabbit polyclonal 1:200 1:1000 Alomone, APR-004
Glial ﬁbrillary acidic protein (GFAP) Mouse, clone G-A-5 1:200 1:400 Sigma, G3893
Synaptophysin Mouse, clone VP-38 1:200 1:2000 Sigma, S5768
Brn3a Goat polyclonal 1:500 1:500 Santa Cruz sc 31984
JNK1/JNK2 (phospho-Thr183/Tyr185) Rabbit polyclonal – 1:500 Signalway Antibody #11504
SAPK/JNK Rabbit polyclonal – 1:500 Cell Signaling #9252
Phospho-p38 MAP Kinase (Thr180/Tyr182)) Rabbit polyclonal – 1:500 Cell Signaling #9211
p38 MAP Kinase Rabbit polyclonal – 1:500 Cell Signaling#9212
Cleaved Caspase-3 (Asp175) Rabbit polyclonal – 1:500 Cell Signaling #9661
Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) Rabbit polyclonal – 1:2500 Abcam Ab9485
Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) Rabbit polyclonal – 1:500 Santa Cruz sc166574
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2.4. Quantiﬁcation of ganglion cell loss
Confocal images sections were obtained using 40x magniﬁcation in
glaucomatous mice and their respective control mice. Sections stained
with antibody against Brn3a at diﬀerent ages (3 and 15 months) were
used to quantify the number of remained RGCs. All measurements were
analysed in several retinal regions (central and peripheral areas) of at
least 4 mice in seven captured micrographs from each eye and age
point. Images were processed with the NIH ImageJ 1.42 software
(Schneider et al., 2012) to perform morphometric analysis of the con-
focal images; the quantiﬁcation of RGCs was done manually using the
cell counter plugin.
2.5. Western blot analysis
Western blot experiments were performed using control and injured
retinas at diﬀerent stages of age, 3 and 15 months (n=10 mice for each
group). Samples were thawed and homogenized in lysis buﬀer (1%
Nonidet P-40, 0.1% SDS, 0.5% deoxycolic acid, 0.15M NaCl in 0.05M
Tris−HCl buﬀer, pH 8.0) supplemented with protease inhibitors (1 mM
PMSF, 10 μg/mL leupeptin, 5 μg/mL pepstatin, 10 μg/mL aprotinin,
1 mM sodium ﬂuoride and 2mM sodium orthovanadate). Tissue ex-
tracts were incubated for 30min on ice and centrifuged at 15,000 rpm
for 15min at 4 °C. Protein concentration was quantiﬁed spectro-
photometrically using the Bradford assay (Quickstart Bradford Dye
Reagent 1x, Bio-Rad Laboratories, Alcobendas, Madrid, Spain). Retinal
extracts (30–150 μg depending of the analyzed protein) were re-sus-
pended in 2x Laemmli´s sample buﬀer (glycerol, SDS, 2-mercap-
toethanol, bromophenol blue in Tris−HCl buﬀer) at a 4:1 ratio and
were loaded on a 10% SDS-polyacrilamide gel and transferred to ni-
trocellulose membrane (Hybond-P PVDF membranes, GE Healthcare
Life Science, Germany). Blots were washed and blocked with 5% non-
fat dry milk in TBS buﬀer (Tris−HCl, NaCl, 0.1% Tween 20) for 1 h at
room temperature and were incubated overnight at 4 °C with every one
of the diﬀerent commercial antibodies (see Table 1). Horseradish per-
oxidase-conjugated secondary antibodies (Jackson ImmunoResearch,
West Grove, PA, USA) at a 1:10,000 dilution for 1 h at room tempera-
ture were used. Detection was performed using an enhanced chemilu-
miniscence system (ECL, Amersham Phamacia Biotech). Mouse mono-
clonal glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH), and
JNK or p38 policlonal antibodies served as a loading control.
Films from western blots were digitized with Gel Logic 200 Imaging
System (Kodak, Rochester, NY, USA). Densitometric quantitation of
protein bands was accomplished using Kodak Molecular Imaging soft-
ware (Kodak, Rochester, NY, USA) and values obtained for each protein
were normalized to respective densitometric GAPDH or total protein
(JNK and p38) in signaling pathways to check that all wells were loaded
with the same amount of protein. For each quantiﬁed protein the results
of at least three independent experiments were analyzed, each con-
taining a minimum of two biological replicates.
2.6. RNA isolation and reverse transcriptase-PCR
Total RNA was isolated from the glaucomatous and control retinas
at 3 and 15 months of age (n= 4 mice for each group) using the
Nucleospin RNA/Protein Kit (Macherey-Nagel, Düren, Germany) ac-
cording to the instructions of the manufacturer and 250 ng was reverse
transcribed using SuperScript® III First-Strand synthesis system Kit
(Invitrogen, Thermo Fisher Scientiﬁc, Waltham, MA USA).
The P2X7-speciﬁc primers (forward 5′-GCACGAATTATGGCACC
GTC-3′ and reverse 5′-ACACCTGCCAGTCTGGATTCCT-3′) that have
been previously described (Sanchez-Nogueiro et al., 2005) were em-
ployed for ampliﬁcation of P2X7. Glyceraldehyde-3 phosphate dehy-
drogenase (GAPDH) was used as an internal control and GAPDH-spe-
ciﬁc primers (forward 5′-ACCACAGTCCATGCCATCAC-3′ and reverse
5′-TCCACCACCCTGTTGCTGTA-3′) were purchased from Clontech
(Clontech, Mountain View, CA, USA). Reactions were performed using
TITANUM™ Taq DNA polymerase (Takara Bio Inc., Japan). For P2X7
ampliﬁcation, reaction conditions were 95 °C for 3min, followed by 35
cycles at 95 °C for 1min, 68 °C for 1min, 72 °C for 1min and ﬁnally
72 °C for 3min. The thermal cycling conditions for GAPDH ampliﬁca-
tion were 95 °C for 5min, followed by 30 cycles at 95 °C for 45 s, 60 °C
for 45 s, 72 °C for 2min and 72 °C for 7min.
PCR products were separated by electrophoresis on 1.5% agarose
gel, stained by ethidium bromide and quantiﬁed using a Kodak GL 200
Imaging system and Kodak Molecular Imaging software (Kodak,
Rochester, NY, USA).
2.7. Measurement of caspase-3 activity
Caspase-3 activity was determined by Caspase-3 Fluorescence Assay
Kit (Cayman Chemical Company Ann Arbor, MI, USA). DBA/2J and
C57BL/6J retinas were dissected from the enucleated eyes at 3 or 15
months (n=4 mice for each group). Extra-caution was paid to avoid
damaging the retinas as a prior step to place them in cold PBS to wash
the samples. The tissue was homogenized in a lysis buﬀer (50mM
HEPES, pH 7.4, 100mM NaCl, 0.1% 3-[(3-cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate, 10mM DTT, and 100mM EDTA,
10 μg/ml of leupeptin, 2 μg/ml pepstatin, 2 μg/ml aprotinin, 1 mM
PMSF, and 0.03% digitonin on ice for 30min. The samples were cen-
trifuged at 15,000g for 15min at 4 °C and supernatants were transferred
to an individual well of a 96-well plate. Cell lysates were tested with
diﬀerent dilutions and incubated with 100 μl of caspase-3 N-DEVD-N'-
morpholinecarbonyl-rhodamine 110 substrate (Ac-DEVD-N´-MC-R110;
Peptide Institute, Osaka, Japan). Caspase-3 was assessed by measuring
the cleavage of ﬂuorogenic substrate and was monitored by measuring
excitation at 485 nm and emission at 535 nm on a plate reader
(Fluoroscan Imaging Systems, Bedford, MA) over time. The arbitrary
values were presented as the mean ± SEM of three experiments with
DBA/2J and control samples.
2.8. Statistical analysis
Quantitative results of morphometric analyses were analyzed by
statistical software (GraphPad Prism® 7; GraphPad Software, Inc., La
Jolla, CA, USA). For statistical studies, Student’s t-test was performed to
compare the number of RGC found at each age-point compared with
control mice retinas. All analyzed images were captured in the same
regions of the retina (from the peripheral to middle-central retina) to
assure the suitable count of cells.
The amount of protein or mRNA presents in each spot was measured
with densitometry by integration of the optical density over the spot’s
area. Numerical data were processed by a spreadsheet (Microsoft
Excel), and statistical analyses were carried out using InStat 3 software
(GraphPad Software). Statistical comparisons at diﬀerent age stages
between the glaucomatous and control strains were performed using
the Student´s t-test with a conﬁdence interval of 95% followed to
Wilcoxon’s test or one way ANOVA test followed by Bonferroni test
correction to determine statistical signiﬁcance.
Statistical comparisons of protein expression in glaucomatous and
control mice were performed using Student´s t-test with a conﬁdence
interval of 95% with Welch correction followed to Kolmogorov-
Smirnov method using InStat 3 software (GraphPad Software).
3. Results
3.1. Assessment of retinal function in glaucomatous mice
To determine possible electrophysiological deﬁcits during the de-
velopment of glaucomatous degeneration, the scotopic threshold re-
sponse (STR) of the ERG was assessed in DBA/2J and control mice. ERG
recordings were obtained at 3 and 15 months of age from right eyes in
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12 DBA/2J and in 12 C57BL/6J control mice. The amplitudes of posi-
tive STR (pSTR) and negative STR (nSTR) increased exponentially, in
both control and glaucomatous mice as the intensity of the light stimuli
increased (Fig. 1). A decrease in the magnitude of pSTR was observed in
the responses of DBA/2J mice during the progress of the pathology.
Fig. 1 shows representative traces of the ERG recorded in response to
ﬂash stimuli of increasing intensity ranging from -5.00 to -2.94 log
cd·s·m−2 in DBA/2J and C57BL/6J mice, respectively. Statistically
signiﬁcant diﬀerences were observed between 15 months glaucomatous
and 3 months glaucomatous and control group. The pSTR trace am-
plitudes in DBA/2J mice decreased at 15 months of age by 52.7%, with
a 95% conﬁdence interval (t-test; p < 0.001). STR recordings from
control mice showed no signiﬁcant diﬀerences in the amplitudes of the
pSTR during aging. These data suggest that this signiﬁcant dysfunction
of the inner retina may be correlated by a neuronal death progress.
3.2. Increase of P2X7 receptor levels in retina of DBA/2J mice
P2X7 immunoreactivity was evaluated in vertical cryostat sections
of the mice retinas. The P2X7R was detected in the outer (OPL) and
inner (IPL) plexiform layers, inner nuclear layer (INL) and ganglion cell
layer (GCL) (Fig. 2 A–C) conﬁrming previous reports. The distribution
pattern of P2X7 immunostaining was similar in younger mice of both
strains (C57BL/6J and DBA/2J at 3 months). The glaucomatous mice
retinas displayed signiﬁcant increased immunoreactivity levels for the
P2X7R at 15 months. Strong punctate immunoreactivity was observed
in the GCL, IPL, and OPL (Fig. 2C). The P2X7R immunolabeling was
measured carefully in GCL to demonstrate the protein increase in these
neurons (Fig. 2A–C). Depending on the histological section, it was
found a lack of RGCs (Fig. 2C) or the remaining RGCs with a strong
P2X7 immunoreactivity (Fig. 2D). To quantify the up-regulation of
P2X7 receptors, the level of this protein was analyzed by western blot in
control and glaucomatous retinas. P2X7 receptor levels were increased
(78%, p < 0.0005) in 15 months old DBA/2J mice, when compared to
control mice (Fig. 2F). A signiﬁcant increased level was observed
comparing normal and glaucomatous mice at 3 months of age (36%,
p < 0.0005).
Using RT-PCR, mRNA P2X7 levels in both strains at diﬀerent ages
were analyzed (Fig. 2G). Increased mRNA levels were detected in DBA/
2J mice at 15 months (70%, p < 0.005) as compared to the control
mice at the same age and DBA/2J or control mice at 3 months old. This
ﬁnding is in agreement with western blot and immunohistochemistry
results.
Fig. 1. Scotopic representative ERG responses
recorded from control (blue traces) and glau-
comatous (red traces) mice in response to ﬂash
stimuli of increasing intensity (A–B). The ERG
responses were elicited by weak light stimuli
from −2.94 to −5.00 log cd·s/m2. A sig-
niﬁcant reduction was observed in DBA/2J
mice at 15 months comparing with the control
mice. (C) pSTR response as a function of sti-
mulus light intensity from C57BL/6J and DBA/
2J at 3 and 15 months. Plot data correspond to
mean values ± SD (n= 12). A signiﬁcant re-
duction in pSTR amplitude can be observed in
DBA/2J between 3 and 15 months of age
(p < 0.001) and when compared with control
mice at 15 months (p < 0.001).
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3.3. Morphological alterations in glaucoma model
Immunohistochemistry studies were carried out to identify mor-
phological alterations in DBA/2J glaucomatous mice. Speciﬁc retinal
markers were evaluated in the progression of disease and their possible
relationship with P2X7R. The results reveal signiﬁcant changes in-
cluding a loss of synaptic vesicles, the presence of retinal gliosis, RGC
death and abnormal expression of RGC neuroﬁlaments associated with
Fig. 2. Up-regulated P2X7 receptor and Brn3a decrease
during the development of the pathology (from 3 to 15
months) in DBA/2J and control mice retina. (A–D) P2X7 and
Brn3a immunostaining in mice retinas. P2X7 im-
munoreactivity in retinal ganglion cells (and retinal inner
layers) during the development of glaucoma. P2X7R were
increased in DBA/2J retina from 3 to 15 months of age (B, C
and D). In normal retinas (C57BL/6J and DBA/2J at 3
months), Brn3a immunoreactivity was observed in RGCs.
However, when the retinal impairment progresses Brn3a
immunoreactivity was observed in a smaller population of
Brn3a, and this correlates with RGC loss. (D) High magniﬁ-
cation from DBA/2J retina at 15 months shows the strong
P2X7 immunoreactivity in RGCs. All images were acquired
at 20x magniﬁcation. Merge. Scale bars: 20 μm. (E)
Quantiﬁcation of the number of RGCs in vertical sections
labelled with Brn3a in control (C57) and glaucomatous
(DBA) mice at 3 and 15 months of age and expressed as
mean ± SEM. Student’s t-test (*p < 0.05; **p < 0.01;
***p < 0.001). (F) Western blot on retinal extracts at 3 and
15 months in C57BL/6J and DBA/2J mice, showing an in-
creased expression of P2X7R in pathological mice. GAPDH
were used as a control to normalize P2X7 levels. Data were
represented as mean ± SEM. Student’s t-test
(***p < 0.001). (G) RT-PCR was done using primers as
described in material and methods. GAPDH was used as an
internal control. The values of the ratio of P2X7 to GAPDH
were calculated and data were normalized by threshold re-
cordings in control and glaucomatous mice at 3 and 15
months.
mRNA levels of the control, deﬁned as 100% (*p< 0.05;
**p< 0.01). (H) Western blot analysis of the Brn3a expres-
sion showed a signiﬁcant decrease between 3 and 15 months
in DBA/2J mice, GAPDH were used as a control to normalize
Brn3a levels. Data were represented as mean ± SEM.
Student’s t-test (***p < 0.001).
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neurodegeneration or neuronal damage.
3.3.1. Retinal ganglion cell loss
The expression of Brn3a was observed in the GCL of control and
pathological retinas (Fig. 2 A–C). At 15 months, when the retinal dys-
function was detected, Brn3a immunoreactivity had decreased due to
RGC loss. The quantiﬁcation of Brn3a expression by western blot
showed a reduction of 64.3% (p < 0.0005) (Fig. 2H). In addition,
when the number of RGCs in control and injured sections were counted
to correlate the reduction in protein levels (Fig. 2E) a decrease of
36.71% p < 0.005 was observed. Double labeling with the neuronal
marker Brn3a revealed that the majority of RGCs were showing a po-
sitive P2X7 immunostaining (Fig. 2D). A signiﬁcant P2X7R im-
munostaining increase was found in the small population of surviving
RGCs (Fig. 2D). These results suggest the possible contribution to
P2X7R-mediated RGC neurodegeneration.
3.3.2. Reactive gliosis in glaucomatous mice
GFAP, extensively used as a marker for reactive gliosis, was ana-
lyzed by western blot in glaucomatous and control mice at diﬀerent
ages (3 or 15 months). In older DBA/2J mice retinas, GFAP was in-
creased 3.74 fold (374% of increase) in glial cells in response to neu-
ronal damage comparing with control mice (p < 0.01). The GFAP le-
vels were increased with aging in glaucomatous mice 1.84 (84% of
increase) fold (p < 0.01) in contrast with DBA/2J 3 months old (Fig. 3
D–E). Immunohistochemical results (Fig. 3) indicate that when com-
pared to control mice, GFAP-immunoreactivity was increased in as-
trocytes and Müller cells in a time-dependent manner (Fig. 3 A–C) in
DBA/2J mice.
3.3.3. Loss of synaptic connectivity
In order to clarify the possible alteration in retinal circuitry, the
connectivity between photoreceptors and second order retinal neurons
was studied using synaptophysin (SYP) marker. The P2X7 and SYP
expression were analyzed to establish their possible contribution with
the concomitant inner retinal damage. In 15 months old DBA/2J retinas
(Fig. 4C) a diﬀerent pattern of expression of the SYP synaptic vesicle
protein with respect to DBA/2J mice at 3 months old was detected. In
the DBA/2J mice, it is observed a reduction of the photoreceptor axon
terminals. The levels of Syp were analyzed by western blot technique.
There was a 30.36% reduction in DBA/2J mice of 15 months of age
when compared to younger mice (p < 0.05). However, in C57BL/6J
mice there were no signiﬁcant changes detected with age (Fig. 4D).
Glaucomatous degeneration may cause synapse alteration. The SYP is
an integral membrane protein of the synaptic vesicles involved in
multiple functions as exocytosis, neurotransmiter delivery and retinal
development. Double immunolabeling experiments with P2X7 and SYP
could reveal the axon photoreceptor terminal damaged and this may
lead to apoptotic processes in second order neurons.
3.3.4. Neuroﬁlaments
In whole-mounted retinas we have studied qualitatively the ex-
pression of pNFH and P2X7 receptor, a well-established degeneration
marker of RGC lesion, according to its abnormal cellular distribution
pattern, and a mediator in neuronal death, respectively; at two ages, 3
and 15 months (Fig. 5).
At early stages (3 months old) the qualitative study of P2X7 and
pNFH co-expression on whole-mount retinas revealed no morphological
signs of neuronal degeneration in the RGC population of DBA/2J mouse
at this age (Fig. 5A’, A’’, B’, B’’, C’, C’’). Its appearance was like that
observed in control retinas (C57BL/6J mice) at the same age (Fig. 5A,
B, C). At this age, pNFH positive RGC (pNFH+RGC) immunoreactivity
shows the typical expression pattern described in healthy neurons by
other authors (Parrilla-Reverter et al., 2009) (Fig. 5A-A’’). In the in-
traretinal aspect of the RGC, the expression of pFNH appears restricted
mainly to the distal portion of the axons, where axons are tightly
packed in bundles arranged radially in the central region of the retina
around the optic disk. There were no signs of pNFH up-regulation in the
RGC soma, proximal axon or dendrites. In the peripheral and middle
retina, there was no pNFH positive immunoreactivity or it was scarce
and sparse, like in control retinas. The expression of the P2X7 receptor
was absent in the RGC population, only it was observed as slight P2X7
positive immunoreactivity in the innermost vascular plexus of the re-
tina of both control (C57BL/6J) (Fig. 5B, C) and DBA/2J (Fig. 5 B’, B’’,
C’, C’’) mice at 3 months of age. These morphological data about ex-
pression of both neurodegeneration markers were consistent with
functional data observed in these animals, where there was no sign of
abnormal function in the retina (Fig. 1).
At 15 months of age (Fig. 5 D-D’’, E-E’’, F-F’’) immunodetection of
both markers (pNFH and P2X7) on whole-mounted retinas made easy
correlate the observed neuronal degeneration in our results with the
typical and characteristic patched pattern of neuronal degeneration in
the retina of DBA/2J mice (Fig. 5D’, D’’, E’, E’’). This mouse linage is
characterized by a large inter- and intra-individual variability during
the development of the pathological condition along the time. It was
possible to observe old mice without retinal pathological signs or, even,
animals that only developed a total or partial lesion in one of both
retinas. Degeneration pattern was revealed by diminution in the density
of axonal bundles in the central retina and abnormal pNFH positive
immunoreactivity in the RGC soma and proximal axon. These RGCs
were scattered throughout the retina, without a clear regionalization,
alternating with typical pNFH immunopositive axons from healthy
RGC. Axons and nerve ﬁber bundles lose their straight trajectory and
those observed showed a wavy line path characteristic of the axons
from RGCs in degeneration (Fig 5D’, D’’). The expression of P2X7 was
mainly restricted to the cell body of pNFH+RGC in animals with se-
verely damaged retinas or those where the degeneration was not so
obvious (Fig. 5E’, E’’, F’, F’’). P2X7 was not immunodetected in RGC
from control animals (Fig. 5E, F). However, it was striking the down-
regulation of the expression of P2X7R in the vascular system of the
DBA/2J mice at 15 months of age, because this downregulation was not
observed in control mice of the same age neither in DBA/2J mice at 3
months of age and its controls (Fig. 5E-E’’, F-F’’). This loss of vascular
immunostaining was observed in retinas with clear signs of degenera-
tion and in those in which the glaucomatous condition was not detected
on the base of an aberrant pNFH expression in RGC.
3.4. Activation of p38, JNK and apoptotic processes mediated by caspase-3
in retinal ganglion cells
3.4.1. P38 and JNK phosphorylation
The possible implication of MAPKs was evaluated during the
apoptotic process induced by the development of glaucomatous de-
generation (Fig. 6A, B). The activation of two members of the MAPK
family, JNK54/46 (Fig. 6A) and p38 (Fig. 6B), was monitored by
western blot analysis with antibodies that recognize the activated
phosphorylated forms of the two kinases.
Retinal protein lysates were analyzed at diﬀerent ages comparing
the evolution of the pathology and with control mice. The expression
levels of phospho-JNK54/46 were up-regulated in injured retinas
ﬁnding 79.35% of increase, when comparing with the control mice at
15 months. A statistically signiﬁcant increase of 55.10% p < 0.005
was observed in DBA/2J mice with age (Fig. 6A). In addition to JNK,
the expression levels of phosphorylated p38 protein (Fig. 6B) were
higher at 15 months than at 3 months in the DBA/2J mice (an increase
of 342%), when compared with control mice at 15 months (p < 0.001,
Fig. 6B). Non-signiﬁcant age-dependent decrease was observed in the
phosphorylated proteins levels obtained at 3 or 15 month old C57BL/6J
mice. The total MAPK protein level p38 and JNK54/56 levels remained
constant over the time course (Fig. 6A, B right panels).
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3.4.2. Caspase-3 activation
In previous studies, we characterized the loss of RGC in this murine
glaucoma model (Perez de Lara et al., 2014). Therefore, to evaluate the
cell death produced by apoptosis we analyzed the expression of cas-
pase-3. Western blot analysis of retinal protein extracts showed weakly
expression in non-pathological retinas (control retinas and younger
DBA/2J retinas) but during the development of the pathology its ex-
pression increased signiﬁcantly (279.82% p < 0.001) when compared
to C57BL/6J control matched mice (Fig. 6C).
Immunoblot results were correlated with caspase-3 activity. Lysate
retinal extracts were collected from control and DBA/2J mice at 3 and
15 months. A large increase in Ac-DEVD-N´-MC-R110 cleavage was
observed in glaucomatous retinas. As shown, in Fig. 6, caspase-3 ac-
tivity was statistically increased at 15 months of age in DBA/2J mice
(288%, p < 0.001) compared with wild type retinas at 3 or 15 months
and DBA/2J retinas at 3 months (Fig. 6D).
4. Discussion
In the present study, we assess the increased expression of the ATP-
gated P2X7R in the retina of DBA/2J glaucomatous mice during the
development of the pathology. This increase can be correlated with
speciﬁc retinal markers. GFAP, SYP, NF and Brn3a expression change in
this animal model as the pathology advances. Furthermore, the present
work describes the possible role of P2X7 nucleotide receptor on p-p38
and p-JNK activation and their possible implication with RGC apoptotic
death through caspase-3 pathway.
4.1. Loss of RGC in DBA mice and retinal dysfunction
DBA/2J mouse is a well-stablished model of glaucoma characterized
by a progressive loss of RGCs and optic nerve excavation (Nagaraju
et al., 2007; Buckingham et al., 2008; McKinnon et al., 2009). In this
pigmentary glaucoma mice model, the possible mechanisms of RGC
death were investigated. A qualitative and quantitative reduction of
Brn3a expression during the progress of the pathology in DBA/2J mice
were detected. In Brn3a immunodeteted DBA/2J retina cross-sections,
the number of RGCs signiﬁcantly decreased with age, in accordance
with previous studies (Fernandez-Sanchez et al., 2014). Our results are
according to previous ﬁndings (Perez de Lara et al., 2014) and the
degeneration in retinal patches described by Fernandez-Sanchez and
co-workers (Fernandez-Sanchez et al., 2014). These values were con-
ﬁrmed with the down-regulated protein levels detected by western blot
(Fig. 2). RGCs loss in this model is a consequence of iris pigment
Fig. 3. Glial cells are activated in glaucomatous retinas. (A–C) Glial cell activation was assessed by immunostaining retinal cross sections with antibodies against
GFAP (green) in C57BL/6J (A) and DBA/2J retinas (B–C). In the C57 and 3 months old DBA retinas, GFAP immunoreactivity was selectively localized to astrocytes
(in mouse retina there is no detectable GFAP in Müller cell endfeet). In 15 months old DBA/2J mice, GFAP reactivity of Müller cells extended from the inner to the
outer retina. On merged images, P2X7R was found to co-localize strongly with GFAP in the retina of glaucomatous mice. All images were acquired at 20x mag-
niﬁcation. Merge. Scale bars: 20 μm. (D) Western blot analysis of the GFAP levels in control and glaucomatous retina at 3 and 15 months. Membrane was probed with
anti-GAPDH antibody as a loading control. Student´s t-test (**p < 0.01).
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dispersion (IPD) and iris stromal atrophy (ISA) (John et al., 1998; Saleh
et al., 2007). Because of the ISA and IPD mutation are involved in de-
fects in melanin synthesis promoting cytotoxicity. The detached pig-
ments insult the ocular drainage structures and IOP increase con-
comitantly (Anderson et al., 2002, 2006). Based on these ﬁndings,
DBA/2J RGCs degenerate accompanied by the reduction of the scotopic
threshold response (STR) at 15 months which indicates a loss of RGC
function.
4.2. P2X7 receptor and the glaucoma pathogenesis
Diﬀerent models of neurodegeneration associate P2X7 receptors as a
candidate involved in the pathogenesis of neurodegenerative disorders
(Diaz-Hernandez et al., 2009, 2012; Jimenez-Pacheco et al., 2013).
Altered extracellular ATP concentrations and activation of P2X7 may
contribute to the pathologic loss of RGC and retinal dysfunction (Resta
et al., 2005; Reigada et al., 2008; Puthussery and Fletcher, 2009; Hu
et al., 2010; Sugiyama et al., 2010; Niyadurupola et al., 2013). Fur-
thermore, previous in vitro studies have demonstrated the involvement
of ATP in induced neuronal apoptosis through P2X7 receptor. In fact,
stimulation of P2X7 receptor with Benzoyl-ATP induced apoptosis in
cultured RGC of rat (Zhang et al., 2005) and hypoxia or higher ocular
pressure-induced RGC death were mediated by P2X7 receptor (Reigada
et al., 2008; Mitchell et al., 2009; Sugiyama et al., 2010). In the present
study we observed up-regulation of P2X7R in glaucomatous mice at 15
months. Increasing P2X7 receptor levels was more remarkable in the
inner retina (GCL and IPL), in accordance with progressive morpholo-
gical alterations. P2X7R stimulation may induce RGC apoptosis in ad-
vanced stages, and thus abolish Brn3a transcription factor expression.
This would be consistent with evidence from isolated rat RGCs where
P2X7R stimulation led to calcium overload, caspase activation and
subsequent apoptosis (Zhang et al., 2005). The signiﬁcant RGC loss was
evident by a signiﬁcant diminution in axonal density as the pathology
progresses when RGCs were reduced and the abnormal pNFH positive
immunoreactivity was present, using this protein as axonal marker
(Fig. 5). Moreover, this ﬁnding correlates with morphological altera-
tions and molecular changes in the DBA/2J mice.
P2X7R expression has been detected in mice astrocytes in a glau-
comatous model (Vessey and Fletcher, 2012). In the present work an
increase in GFAP expression at the age of glaucoma onset has been
detected. Astrocytes labeled with GFAP were found to co-localize with
P2X7R in the mouse retina, as carefully described by Vessey and
Fletcher (Vessey and Fletcher, 2012). The P2X7R presence suggests the
implication of this receptor in regulating microglial activity (Monif
et al., 2010). The presence of activated P2X7R may be involved with
inﬂammatory responses in inner retina as described in vitro (Panenka
et al., 2001). In addition, an increase of P2X7R was observed in OPL
accompanied by a diminished synaptic connectivity in older animals.
Increased levels of P2X7R were detected in synaptic terminal suggesting
the possible apoptotic processes involved due to the impairment of
retinal circuitry (Puthussery et al., 2006; Heiduschka et al., 2010). This
result is in agreement with previous morphological ﬁndings where a
loss of synaptic contacts in the OPL in an aging-dependent manner was
observed in this model (Fernandez-Sanchez et al., 2014). This may
suggest the implication of P2X7 in photoreceptor pathway signaling
and other indirect mechanisms that could contribute to P2X7R-medi-
ated RGC neurodegeneration (Puthussery et al., 2006; Vessey and
Fletcher, 2012). Moreover, increased extracellular ATP levels at ad-
vanced stages contribute to P2X7R activation and could be implicated
in retinal microvasculature damage. Several reports suggest that P2X7
activation triggers cell death in inﬂammatory retinal diseases
(Sugiyama et al., 2004, 2005). It is tempting to suggest that upregula-
tion of this receptor may mediate apoptosis in the retinal micro-
vasculature and epithelial cells could be suﬀering morphological re-
structuration and integrity loss as the pathology progresses in aged (15
months old) glaucomatous mice.
Fig. 4. Immunolabeling of synaptophysin
(green) and P2X7R (red) in control and glau-
comatous retinas at diﬀerent ages (3 and 15
months) (A–C). At 15 months (C), SYP im-
munostain shows a dissipation and clustering
pattern of the label in the OPL and a more
prominent clustering in the SYP label in the IPL
than at 3 months (B) and control (A). All
images were acquired at 20x magniﬁcation and
merge. Scale bars: 20 μm. Western blot analysis
of the SYP levels in control and glaucomatous
retina at 3 and 15 months (D). The amount of
SYP decreased signiﬁcantly during the progress
of the pathology (E). Membrane was probed
with anti-GAPDH antibody as a loading con-
trol. Student´s t-test (*p < 0.05).
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Fig. 5. Retinal ganglion cell axonal pattern in control and glaucomatous mice (A–F). Representative illustrations from whole-mount retinas of control (C57BL/6J)
and DBA/2J mice at 3 and 15 months of age are showed. At 3 months old, in control (A, C) and DBA/2J (A’, A’’, C’, C’’) mice intense pNFH-expression is detected in
bundles of RGC axons radially converging towards the optic disk within the central area of the retina. Note that in control and 3 months old DBA/2J retinas pNFH-
expression do not reach the periphery of the retina nor is observed in the cell bodies or dendrites of RGCs. P2X7R-expression is null in the RGC population in control
(B, C, E, F) and in 3 months old DBA/2J (B’, B’’, C’, C’’) retinas. Notice that retinal innermost vascular plexus shows P2X7R positive immunoreaction at 3 months (B-
B’’). There is no co-expression of both markers at 3 months stage (C-C’’). At 15 months of age comparing with control retinas (D), there are changes of the pNFH-
expression pattern in DBA/2J retinas (D’, D’’). The number of immunopositive RGC axons diminishes in the center of the retina and RGC somas with abnormal pNFH-
expression appear scattered throughout the retina (D’, F’) or decrease dramatically throughout the retina and the abnormal pNFH-expression is restricted to the RGC
somas (D’’, F’’). Note the strong variability in the degree of retinal degeneration in DBA/2J mice retinas (D’’, F’’). Comparing with control (E, F), P2X7R-expression
appear restricted to RGC somas (E’, E’’) in co-expression with pNFH (F’, F’’; arrows) in degenerated retinas. There is no vascular plexus P2X7R labeling in neuro-
degenerated retinas (E’, E’’), in contrast with that observed in control (E). Detail of square region in D’’ and E’’ is showed in F’’ to show the double labeling of the RGC
somas in retinas with severe neurodegeneration. Scale bar 500 μm (A-A’’, B-B’’, D-D’’, E-E’’). Scale bar 50 μm (C-C’’, F-F’’).
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4.3. Involvement of p38 and JNK MAP kinases in glaucomatous
degeneration
The P2X7 receptor has been associated with multiple signaling
cascades, resulting in activation of phospholipase D, cytokine release,
cytoskeletal rearrangements and MAPKs (Skaper et al., 2010). Several
studies have shown that activation of P2X7 receptor leads to down-
stream activation of p38 (Ono and Han, 2000; Armstrong et al., 2002;
Donnelly-Roberts et al., 2004) and JNK MAPKs (Suzuki et al., 2004).
The cell death of GCL and INL neurons in glaucoma is known to involve
the activation of JNK and p38 intracellular pathways (Kikuchi et al.,
2000; Levkovitch-Verbin et al., 2005; Munemasa et al., 2005, 2006;
Bessero et al., 2010; Donovan et al., 2011). Increased JNK and p38
MAPK signaling has also been documented in human glaucomatous
tissue (Tezel et al., 2003). Moreover, it was reported that inhibition of
JNK and p38 protects neurons from retinal NMDA-induced
neurotoxicity (Munemasa et al., 2005). Considering this, recent studies
suggest a protective role of P2X7 receptor antagonists (Di Virgilio et al.,
2001; Franke et al., 2004; Jun et al., 2007; Diaz-Hernandez et al., 2009;
Chen et al., 2013). In the present study we have detected alterations in
the expression of several proteins related to RGC death in the retina of
DBA/2J mice. Our data showed an activation of the phospho-MAPK
family members JNK and p38 in injured retinas compared with the
control mice at 15 months (Fig. 6). The ﬁndings obtained from the
western blot analysis showed diﬀerent expression proﬁles of the MAPK
members, suggesting diﬀerent roles of JNK and p38 proteins in P2X7-
induced retinal changes. Our results showed the activation of MAPK
signaling in injured up-regulated P2X7R retinas. Overall, these ﬁndings
suggest that JNK and p38 pathways, are pro-apoptotic in P2X7 induced
ganglion cells death.
Fig. 6. Western blot time-course analysis of
JNK, p38 and caspase-3 (A–C) and retinal ac-
tivity of caspase-3 (D) in the glaucomatous and
control retinas. JNK, p38 and caspase-3 are
overexpressed in glaucomatous retinas. (A–C)
Densitometry analysis showed that at 15
months, there was a signiﬁcant increase in JNK
(A), p38 (B) and caspase-3 (C) when compared
with the control and 3 months old glaucoma-
tous DBA/2J retinas. p-MAPKs (JNK and p38)
were not signiﬁcantly aﬀected with age in
control mice. GAPDH was used as a loading
control. Values represent mean ± SD (n=10)
(*p < 0.05;**p < 0.01; ***p < 0.001). (D)
Caspase-3 activation was measured by in-
cubating control and glaucomatous mice re-
tinas with a ﬂuorescent caspase-3 substrate, as
described in Material and Methods. The en-
zyme activity was signiﬁcantly increased in the
DBA/2J retinas at 15 months compared with
the control and younger glaucomatous mice.
Data are presented as mean ± SD (n= 4)
(**p < 0.01; ***p < 0.001).
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4.4. Activation of apoptotic pathways/mechanisms
Neuronal apoptosis induced by P2X7R activation requires ATP re-
leased from excited or damaged cells as consequence of ocular injury.
Extracellular ATP increased levels may be linked to the activation of the
P2X7R in glaucomatous injury (Resta et al., 2007; Reigada et al., 2008).
Recent research shows increased extracellular ATP levels in the DBA/2J
model (Perez de Lara et al., 2015, 2018), which, together with the P2X7
increased receptor expression described in this work, suggests that its
activation may trigger the subsequent underlying intracellular cascades
already described. In this sense, many studies have demonstrated that
the activation of the caspase cascades in neuronal cells plays an im-
portant role in programmed RGC death (Morrison et al., 1997; Sawada
and Neufeld, 1999; Kim and Park, 2005; Zhang et al., 2005; Reichstein
et al., 2007; Sugiyama et al., 2013). Caspase-mediated cell death is
regulated in part by MAP kinase cascades. JNK is known to be involved
in axonal injury signaling and apoptosis (Donovan et al., 2011;
Fernandes et al., 2012; Harder et al., 2012). Several up-regulated pro-
teins have been documented in a model of optic nerve transection
regulating apoptotic pathways (Agudo et al., 2009). Similarly, p38
MAPK activation has been implicated as an upstream of caspase med-
iator developing RGC injury in diﬀerent experimental models of glau-
coma, including optic nerve axotomy, ocular hypertension, and ex-
citotoxic injury (Kikuchi et al., 2000; Manabe and Lipton, 2003; Harada
et al., 2006; Levkovitch-Verbin et al., 2007; El-Remessy et al., 2008).
Furthermore, recent reports describe the inhibition of p38 as a ther-
apeutic target in ﬁltering glaucoma surgery in rabbits (Nassar et al.,
2015) and axonal dysfunction models (Dapper et al., 2013). The dis-
tribution of these stress activated proteins in the mouse retina includes
INL and GCL and its expression levels have been found by proteomic
analysis increased in retinal neurotoxicity (Munemasa et al., 2005;
Bessero et al., 2010), glaucomatous damage (Dapper et al., 2013) and
retinal ischemia (Roth et al., 2003).
All these reports are consistent with the present results describing
the possible connection between stress-activated proteins (p38, JNK)
and caspases (Chen et al., 2013; Dapper et al., 2013). We have de-
monstrated that these proteins expression was signiﬁcantly increased
with age in DBA/2J retinas together with the concomitant apoptotic
RGC death. It was also observed the subsequent caspase-3 activation
through upstream regulation during the progress of glaucomatous de-
generation. We have investigated the protein levels and activity of
caspase-3 in retinal tissue from controls and glaucoma animals. In this
sense, a signiﬁcantly increased activity of caspase-3 at 15 months cor-
related with the observed increased level of the active p20 fragment of
up-regulated protein (Fig. 6).
In this study, the possible involvement of caspase-3 in P2X7 re-
ceptor-induced pathway of MAPK (JNK and p38) activation has been
suggested. The results indicate that a sustained concentration of ex-
tracellular ATP may activate caspase-3 pathway playing a role in cou-
pling the P2X7 receptor to the MAPK signaling cascade. Therefore, the
antagonism of P2X7R may be a possible approach to prevent ganglion
cell death in glaucoma pathogenesis. The inhibition of P2X7R has been
previously reported in diﬀerent models of neurodegenerative diseases.
In vivo administration of a P2X7R antagonist, demonstrated sig-
niﬁcantly reductions in amyloid plaques in Alzheimer disease model via
glycogen synthase kinase-3 (Diaz-Hernandez et al., 2012) and prevent
neuronal apoptosis and induced brain damage in Huntington’s disease
and epilepsy (Diaz-Hernandez et al., 2009; Jimenez-Pacheco et al.,
2013). Similar ﬁndings were described in an induced IOP elevation rat
model (Sugiyama et al., 2013), and in in vivo stimulation of P2X7R (Hu
et al., 2010).
4.5. Conclusions
In summary, we have described the P2X7R, GFAP, SYP, NF ex-
pression and the apoptotic signaling components altered in a mouse
model of human pigmentary glaucoma. These ﬁndings indicate that
events of synaptic loss, GFAP activation, NF deﬁcit and apoptosis could
be involved in the pathogenesis of glaucoma leading to visual dys-
function. Identifying the molecular mechanisms and intracellular
pathways activated to promote cell dysfunction and concomitant neu-
ronal death in this glaucomatous model will provide a basis for devel-
oping and targeting treatments for retinal neurodegenerative diseases.
This study provides evidences of molecular alterations in the retina
associated with glaucomatous damage. MAPK signaling pathways may
be involved in P2X7 activation mediated pathogenesis of pigmentary
glaucoma in DBA/2J retinas. Altered protein levels were found to be
related with impairment of inner retina leaded by apoptotic cascades.
Further studies are necessary to elucidate the role of P2X7 and the
implicated mechanisms underlying RGC injury.
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